SBT2.6 Antibody

What is SBT2.6 and what biological role does it play in Arabidopsis thaliana?

SBT2.6 belongs to the subtilase (SBT) family of serine proteases that are secreted into the apoplastic space of plants. Subtilases in Arabidopsis thaliana function in the extracellular space and play critical roles in plant immunity by participating in pathogen-associated molecular pattern (PAMP) recognition and response pathways. Similar to the characterized SBT5.2a, SBT2.6 may be involved in modulating plant immune responses through proteolytic processing of signaling peptides or pathogen-derived proteins in the apoplast . Research suggests subtilases like SBT2.6 participate in the complex network of extracellular proteases that regulate immunity by processing protein substrates during pathogen challenges, potentially affecting pattern-triggered immunity (PTI) responses .

What applications are validated for the SBT2.6 antibody?

The SBT2.6 antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications . For Western blot applications, the antibody allows detection of SBT2.6 protein from Arabidopsis thaliana samples after separation by SDS-PAGE and transfer to membranes. For ELISA applications, the antibody can be used to quantify SBT2.6 in plant extracts. When designing experiments, it's crucial to include proper positive and negative controls to validate antibody specificity, as cross-reactivity with other subtilase family members remains a possibility due to sequence homology among plant subtilases .

What is the optimal storage protocol for maintaining SBT2.6 antibody activity?

The SBT2.6 antibody should be stored at -20°C or -80°C upon receipt to maintain its activity . Repeated freeze-thaw cycles should be avoided as they can lead to denaturation and loss of antibody function. The antibody is supplied in liquid form containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . For working solutions, antibody aliquots should be prepared in small volumes to minimize repeated freeze-thaw cycles. When handling, always maintain cold chain protocols and use sterile techniques to prevent contamination that could affect experimental outcomes.

How should I validate the specificity of the SBT2.6 antibody in my experimental system?

Validation of antibody specificity is essential, particularly for polyclonal antibodies like the SBT2.6 antibody. A comprehensive validation protocol should include:

• Positive controls: Use purified recombinant Arabidopsis thaliana SBT2.6 protein

• Negative controls: Use samples from SBT2.6 knockout plants or non-plant tissues

• Peptide competition assay: Pre-incubate the antibody with excess immunizing peptide before application to verify that binding is specifically blocked

• Western blot confirmation: Verify a single band of the expected molecular weight

• Cross-reactivity assessment: Test against other closely related subtilases to evaluate potential cross-reactivity

This validation approach ensures confidence in experimental results by confirming that observed signals originate specifically from SBT2.6 rather than from related proteins with similar epitopes .

What is the immunogen used to generate the SBT2.6 antibody?

The SBT2.6 antibody was generated using recombinant Arabidopsis thaliana SBT2.6 protein as the immunogen . This polyclonal antibody was raised in rabbits and subsequently purified using antigen affinity chromatography to enhance specificity . Understanding the immunogen is crucial for predicting potential cross-reactivity with other proteins and for designing appropriate blocking strategies in immunoassays. The use of the full recombinant protein rather than just peptide fragments may provide recognition of multiple epitopes on the SBT2.6 protein, potentially improving detection sensitivity but also increasing the possibility of cross-reactivity with structurally similar subtilases.

How can I distinguish between SBT2.6 and other subtilase family members in immunodetection experiments?

Distinguishing between closely related subtilase family members presents a significant challenge due to high sequence similarity. A multi-pronged approach is recommended:

• Sequential immunoprecipitation: First deplete samples of known cross-reactive subtilases using specific antibodies before probing for SBT2.6

• Genetic controls: Include samples from knockout lines of specific subtilases

• Mass spectrometry validation: After immunoprecipitation with the SBT2.6 antibody, perform mass spectrometry to confirm protein identity

• Epitope mapping: Determine the specific epitopes recognized by the antibody and compare with sequence alignments of other subtilases

• Pre-absorption protocol: Develop a customized pre-absorption protocol using recombinant proteins of closely related subtilases to remove cross-reactive antibodies

Additionally, combining immunodetection with enzyme activity assays using specific substrates can provide functional validation of the detected protein .

What methodological adaptations are needed when using SBT2.6 antibody for investigating plant-pathogen interactions?

When investigating plant-pathogen interactions using the SBT2.6 antibody, several methodological adaptations are necessary:

• Timing considerations: Sample collection must account for the dynamic expression of subtilases during infection, with multiple time points recommended (0, 6, 12, 24, 48, and 72 hours post-infection)

• Subcellular fractionation: Since SBT2.6 functions in the apoplastic space, extraction protocols should separately isolate apoplastic fluid, plasma membrane-associated fractions, and intracellular components

• Fixation procedures: For immunolocalization, aldehyde-based fixatives should be optimized to preserve antigenicity while maintaining cellular structure

• Protein extraction buffers: Include protease inhibitors specific for serine proteases to prevent degradation of SBT2.6 during extraction

• Co-immunoprecipitation adaptations: Use chemical crosslinking to capture transient interactions between SBT2.6 and potential pathogen substrates

This approach allows for comprehensive analysis of SBT2.6 dynamics during pathogen challenge, providing insights into its spatial and temporal regulation .

What are the optimal parameters for using SBT2.6 antibody in chromatin immunoprecipitation experiments?

Although SBT2.6 is primarily an apoplastic protein, investigating potential nuclear functions requires optimized chromatin immunoprecipitation (ChIP) protocols:

• Crosslinking optimization: A dual crosslinking approach using both formaldehyde (1%) and disuccinimidyl glutarate (DSG, 2mM) improves capture of indirect DNA-protein interactions

• Sonication parameters: For plant tissue, 30-second pulses at 30% amplitude with 30-second cooling periods for a total of 15 minutes typically yields 200-500bp fragments

• Antibody concentration: Use 5μg of SBT2.6 antibody per 25μg of chromatin

• Blocking strategy: Include both BSA (5%) and non-immune rabbit IgG in blocking solutions

• Washing stringency: Increase the salt concentration in wash buffers (up to 500mM NaCl) to reduce background

These parameters must be empirically optimized for each experimental system, as chromatin accessibility and nuclear transport of SBT2.6 may vary under different conditions .

How can I integrate SBT2.6 antibody detection with live-cell imaging techniques?

Integrating SBT2.6 antibody detection with live-cell imaging requires specialized approaches:

• Antibody fragmentation: Generate Fab fragments of the SBT2.6 antibody to improve tissue penetration

• Fluorophore conjugation: Directly label purified antibody with pH-stable fluorophores like Alexa Fluor 488 or 647

• Microinjection technique: For single-cell studies, microinject labeled antibodies using femtoliter injection systems

• Permeabilization protocol: Develop a gentle permeabilization protocol using 0.05% Triton X-100 that maintains cell viability

• Correlative microscopy: Combine confocal microscopy with electron microscopy using specialized probes

This integrated approach can provide dynamic information about SBT2.6 localization and trafficking during plant immune responses, though careful controls are needed to confirm that antibody binding doesn't interfere with normal protein function .

What experimental design is optimal for investigating SBT2.6's role in processing pathogen-associated molecular patterns (PAMPs)?

To investigate SBT2.6's potential role in PAMP processing, consider this experimental approach:

• In vitro cleavage assays:

  • Purify recombinant SBT2.6 and incubate with synthetic PAMPs

  • Analyze cleavage products using mass spectrometry

  • Determine kinetic parameters of processing

• Ex vivo analysis:

  • Extract apoplastic fluid from wild-type and SBT2.6 knockout plants

  • Add exogenous PAMPs and monitor processing over time

  • Compare processing patterns between genotypes

• In vivo system:

  • Generate transgenic plants expressing PAMP-reporter fusions

  • Challenge with pathogens and monitor reporter cleavage

  • Compare patterns in wild-type, SBT2.6 overexpression, and knockout lines

This multi-level approach combines biochemical, genetic, and cellular methods to comprehensively characterize SBT2.6's role in PAMP processing, similar to studies conducted with the related SBT5.2a subtilase .

How should I interpret unexpected molecular weight bands when using SBT2.6 antibody in Western blots?

When encountering unexpected bands in Western blots using the SBT2.6 antibody, consider these interpretations and verification approaches:

To verify band identity, perform immunoprecipitation followed by mass spectrometry analysis to definitively identify the detected proteins. Additionally, comparing band patterns between different tissue types, developmental stages, or after various stress treatments can provide insights into potential regulatory processing events .

What are the common pitfalls when using SBT2.6 antibody for immunolocalization studies?

Common pitfalls in SBT2.6 immunolocalization studies include:

• Fixation artifacts: Overfixation can mask epitopes while underfixation causes structural distortion

  • Solution: Test a fixation gradient (0.5-4% paraformaldehyde) and include aldehyde-quenching steps

• Non-specific binding: Particularly problematic in plant tissues with thick cell walls

  • Solution: Use extended blocking (overnight at 4°C) with 5% BSA, 3% milk, and 1% normal goat serum

• Autofluorescence: Plant tissues contain autofluorescent compounds

  • Solution: Include sodium borohydride treatment and select fluorophores with emission spectra distant from chlorophyll

• Accessibility issues: The apoplastic localization may limit antibody penetration

  • Solution: Optimize cell wall digestion with pectolyase/cellulase/macerozyme cocktails

• Signal misinterpretation: Distinguishing between specific localization and artifacts

  • Solution: Include multiple controls (pre-immune serum, peptide competition, knockout tissues) and z-stack analysis

These approaches significantly improve the reliability of immunolocalization data for SBT2.6 studies .

How can I quantitatively analyze SBT2.6 expression changes during pathogen infection?

For quantitative analysis of SBT2.6 expression during pathogen infection, employ these methodological approaches:

• Western blot densitometry:

  • Use housekeeping proteins specific to the same subcellular compartment for normalization

  • Apply non-saturating exposure conditions verified by standard curves

  • Analyze using open-source software like ImageJ with statistical validation

• ELISA quantification:

  • Develop a sandwich ELISA using capture and detection antibodies

  • Create standard curves using recombinant SBT2.6 protein

  • Apply four-parameter logistic regression for concentration determination

• Combined approach:

  • Correlate protein levels with transcript quantification using RT-qPCR

  • Account for time-lag between transcription and translation

  • Include analysis of post-translational modifications using phospho-specific or glyco-specific staining

This multi-method quantification provides robust data on SBT2.6 regulation during pathogen challenges, allowing for accurate interpretation of its role in defense responses .

How can SBT2.6 antibody be used to investigate potential interactions with cold shock proteins in plant immunity?

Building on research with related subtilases like SBT5.2a, which cleaves cold shock proteins (CSPs) , researchers can investigate SBT2.6's potential similar function:

• Co-immunoprecipitation protocol:

  • Use the SBT2.6 antibody conjugated to magnetic beads

  • Perform pull-downs from infected and healthy plant apoplastic fluid

  • Identify binding partners using mass spectrometry, specifically looking for CSPs

• In vitro cleavage assay:

  • Incubate purified SBT2.6 with bacterial CSPs

  • Analyze products using SDS-PAGE and mass spectrometry

  • Compare cleavage patterns with those generated by SBT5.2a

• Functional comparison:

  • Perform complementation studies in SBT5.2a and SBT2.6 knockout plants

  • Challenge with bacteria expressing various CSPs

  • Quantify immune responses to determine functional redundancy

This research direction could reveal whether SBT2.6 shares SBT5.2a's ability to modulate plant immunity through CSP processing, potentially establishing a broader mechanism among plant subtilases .

What methodologies can integrate antibody detection of SBT2.6 with functional proteomics approaches?

Integrating SBT2.6 antibody detection with functional proteomics requires sophisticated methodological approaches:

• Activity-based protein profiling (ABPP):

  • Use serine hydrolase-specific activity probes alongside SBT2.6 immunoprecipitation

  • Compare active enzyme populations before and after pathogen challenge

  • Correlate enzyme activity with protein abundance

• Substrate identification:

  • Perform SBT2.6 immunodepletion followed by differential proteomics

  • Compare proteolytic fragments in wild-type vs. SBT2.6-depleted samples

  • Validate potential substrates with in vitro cleavage assays

• Interaction networks:

  • Combine antibody-based proximity labeling (BioID) with SBT2.6 fusion proteins

  • Identify proteins in close proximity to SBT2.6 in vivo

  • Construct interaction networks relevant to immunity pathways

This integrated approach provides a comprehensive view of both SBT2.6 abundance and function within the complex proteolytic network of the plant apoplast .

How can SBT2.6 antibody be adapted for studying epitope accessibility in different conformational states?

To study SBT2.6 conformational changes using the antibody:

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

  • Compare epitope accessibility with and without antibody binding

  • Identify regions with altered solvent accessibility during activation

  • Map conformational changes induced by pH, calcium, or substrate binding

• Limited proteolysis approach:

  • Perform controlled proteolytic digestion of SBT2.6 in different conditions

  • Use the antibody to immunoprecipitate fragments containing the epitope

  • Identify protection patterns indicating conformational states

• Single-molecule FRET analysis:

  • Label SBT2.6 with donor fluorophore and antibody with acceptor

  • Monitor FRET efficiency changes under different conditions

  • Calculate distance changes reflecting conformational dynamics

These approaches provide insights into how SBT2.6 structure changes during activation and substrate processing, information critical for understanding its mechanistic role in plant immunity pathways .

How does the research application of SBT2.6 antibody differ from antibodies against related plant subtilases?

The research applications of SBT2.6 antibody differ from those targeting other plant subtilases in several key aspects:

When designing experiments, these differences must be considered in the experimental design, particularly when performing comparative studies across multiple subtilase family members. Using antibodies against different subtilases in parallel can provide insights into their specialized versus redundant functions in plant immunity .

What methodological adaptations are required when comparing monovalent and bivalent antibody binding to SBT2.6?

When comparing monovalent (Fab) and bivalent (full IgG) antibody binding to SBT2.6, researchers should consider these methodological adaptations:

• Binding kinetics analysis:

  • Use surface plasmon resonance (SPR) with immobilized SBT2.6

  • Compare association/dissociation rates between formats

  • Calculate affinity constants accounting for avidity effects

• Epitope accessibility studies:

  • Perform hydrogen-deuterium exchange with both antibody formats

  • Compare protection patterns to identify conformational differences

  • Map epitope accessibility in different protein states

• Structural approaches:

  • Use negative-stain electron microscopy to visualize binding complexes

  • Compare binding modes between monovalent and bivalent formats

  • Analyze potential conformational changes induced by each format

These approaches, similar to those used in studying nucleosome-binding antibodies , can reveal fundamental differences in how antibody valency affects recognition of SBT2.6 in its native state, providing insights into protein structure and function .